NCT07177755

Brief Summary

Standard predictors of outcome after cardiac arrest (CA) have substantial limitations in terms of reliability and generalizability. By providing brain structural connectivity maps, or connectomes, advanced MRI techniques, operating through high-strength magnetic field (HF; 1.5 to 3-T), have precisely revealed white and grey brain matter damages induced by CA, and have demonstrated the high sensitivity and specificity of these indicators for predicting neurological outcome after CA. However, HF MRI requires rigid safety precautions, highly trained technicians and patient transport to dedicated hospital imaging suites, hindering the implementation of these promising neuroimaging techniques in the setting of critical illness. Interestingly, a recent report demonstrates the capability of a proof-of-concept very low-field (VLF; 0.064-T) mobile MRI to obtain neuroimaging at the bedside in critically ill patients. Nevertheless, the spatial resolution of VLF-MRI seems low and there is no available evidence about the use of VLF-MRI to extract highly needed new predictors of neurological recovery based on critical brain structural connectomes. The CUBE project holds the promise of providing a radical paradigm shift in the field of neuroprognostication of anoxic coma patients. The current proposal is a "proof-of concept" study which aims to compare for the first time, HF, VLF and enhanced VLF (recon-VLF) structural connectomes from anoxic coma patients and healthy subjects across the time (3 paired HF and VLF brain scan across the first two weeks after CA). To obtain recon-VLF data, the Investigators will use an ensemble of ground-breaking methods to increase the native spatial resolution of VLF-MRI data. The whole brain imaging dataset will be used to prepare future neuroprognostication studies based on fully bedside assessment of brain structural integrity after CA.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
34mo left

Started Sep 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Sep 2025Mar 2029

First Submitted

Initial submission to the registry

May 20, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

September 15, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 17, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2029

Last Updated

September 17, 2025

Status Verified

September 1, 2025

Enrollment Period

3 years

First QC Date

May 20, 2025

Last Update Submit

September 10, 2025

Conditions

Keywords

Anoxic ComaCardiac arrestVLF MRIHF MRIstructural brainconnectomes

Outcome Measures

Primary Outcomes (1)

  • Differences between whole-brain white (WWM-FA) and grey (GMM) matter global metrics independently acquired by HF and VLF-MRI scans very early after coma onset (D0)

    White matter will be assessed by computing the White Matter Fractional Anisotropy (WWM-FA), which ranges from 0 to 1 with lower values related to worse outcomes. Grey matter will be evaluated using Global brain Matter Morphometry (GMM), which encompass both cortical thickness (mm) and deep grey matter volumetry (mm3) assessments, with lower values being associated with poorer outcomes. Both WWM-FA and GMM data will be normalized using brain MRI data obtained from healthy controls (z-scores).

    Day 0

Secondary Outcomes (9)

  • Differences between HF and VLF white (WWM-FA=White Matter Fractional Anisotropy ) and grey (GMM=Global brain Matter Morphometry) matter z-scores.

    Day 0

  • Differences between HF and VLF white (WWM-FA=White Matter Fractional Anisotropy ) and grey (GMM=Global brain Matter Morphometry) matter z-score

    Day 7

  • Differences between HF and VLF white (WWM-FA=White Matter Fractional Anisotropy ) and grey (GMM=Global brain Matter Morphometry) matter z-score

    Day 15

  • Paired comparison between recon-VLF, VLF and HF MRI image's quality, using radiometric information metrics (PSNR, SSIM, ERGAS)

    day 0

  • Paired comparison between recon-VLF, VLF and HF MRI image's quality, using radiometric information metrics (PSNR, SSIM, ERGAS)

    day 7

  • +4 more secondary outcomes

Study Arms (2)

Comatose patients after anoxic brain injury

EXPERIMENTAL

Comatose patients after anoxic brain injury Coma, as indicated by a Glasgow Coma Scale (GCS) ≤ 8 (motor score ≤ 2) immediately after CA resuscitation and before sedation onset

Diagnostic Test: High-field and very-low-field MRI acquisitions

Healthy volunteers

OTHER

Healthy volunteers Adult patients matched in age (plus or minus 5 years) and gender to patients

Diagnostic Test: High-field and very-low-field MRI acquisitions

Interventions

MRI will be early acquired, as soon as possible after patient hospital admission and always in coma state for patients. For both patients and controls each MRI scanning session will encompass pairs of HF and VLF MRI acquisitions, that will be collected the same day. The main MRI sequences will be: T1, T2, FLAIR and DWI. The VLF spatial resolution recommended by the constructor for all these sequences correspond to voxel size is around 1.5mm/1.5mm/5mm. The total brain scanning time is estimated at 30 minutes.

Comatose patients after anoxic brain injuryHealthy volunteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COMA PATIENTS
  • Adult patients (male or female ≥ 18 years).
  • Coma, as indicated by a Glasgow Coma Scale (GCS) ≤ 8 (motor score ≤ 2) immediately after CA resuscitation and before sedation onset.
  • Written informed consent from patient's legal representative.
  • Affiliation to the French social security system
  • HEALTHY VOLUNTEERS
  • Adult patients (male or female ≥ 18 years).
  • Written informed consent.
  • Affiliation to the French social security system

You may not qualify if:

  • COMA PATIENTS
  • Brain death.
  • Coma explained by other cause than CA.
  • Pregnancy.
  • MRI contraindication: medical material not MRI compatible.
  • Hemodynamic instability or respiratory failure precluding patient's transport and MRI scanning.
  • HEALTHY VOLUNTEERS
  • Pregnancy.
  • MRI contraindication: medical material not MRI compatible.
  • Volunteers who do not wish to be informed of an abnormality detected on MRI a posteriori

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Toulouse

Toulouse, France

Location

MeSH Terms

Conditions

Heart ArrestHypoxia-Ischemia, BrainComa

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesBrain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxia, BrainVascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic Manifestations

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Two groups of participants : the first group consists of comatose patients with anoxic brain injury, while the second group consists of healthy participants.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2025

First Posted

September 17, 2025

Study Start

September 15, 2025

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

March 1, 2029

Last Updated

September 17, 2025

Record last verified: 2025-09

Locations